Literature DB >> 33802424

Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives.

Chikashi Watase1, Sho Shiino1, Tatsunori Shimoi2, Emi Noguchi2, Tomoya Kaneda3, Yusuke Yamamoto4, Kan Yonemori2, Shin Takayama1, Akihiko Suto1.   

Abstract

Breast cancer is the second most common origin of brain metastasis after lung cancer. Brain metastasis in breast cancer is commonly found in patients with advanced course disease and has a poor prognosis because the blood-brain barrier is thought to be a major obstacle to the delivery of many drugs in the central nervous system. Therefore, local treatments including surgery, stereotactic radiation therapy, and whole-brain radiation therapy are currently considered the gold standard treatments. Meanwhile, new targeted therapies based on subtype have recently been developed. Some drugs can exceed the blood-brain barrier and enter the central nervous system. New technology for early detection and personalized medicine for metastasis are warranted. In this review, we summarize the historical overview of treatment with a focus on local treatment, the latest drug treatment strategies, and future perspectives using novel therapeutic agents for breast cancer patients with brain metastasis, including ongoing clinical trials.

Entities:  

Keywords:  BRCA gene mutation; CDK4/6 inhibitor; blood–brain barrier; central nervous system; immune checkpoint inhibitor; molecular-targeted therapy; neurosurgery; review; stereotactic radiosurgery (SRS); tyrosine kinase inhibitor; whole brain radiation therapy (WBRT)

Year:  2021        PMID: 33802424      PMCID: PMC7959316          DOI: 10.3390/cancers13051078

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  9 in total

1.  Treatment of breast cancer brain metastases: radiotherapy and emerging preclinical approaches.

Authors:  David Mampre; Yusuf Mehkri; Shashank Rajkumar; Sai Sriram; Jairo Hernandez; Brandon Lucke-Wold; Vyshak Chandra
Journal:  Diagn Ther       Date:  2022-06-20

Review 2.  Actual, Personalized Approaches to Preserve Cognitive Functions in Brain Metastases Breast Cancer Patients.

Authors:  Monika Konopka-Filippow; Dominika Hempel; Ewa Sierko
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

3.  An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth.

Authors:  Lorela Ciraku; Rebecca A Moeller; Emily M Esquea; Wiktoria A Gocal; Edward J Hartsough; Nicole L Simone; Joshua G Jackson; Mauricio J Reginato
Journal:  J Vis Exp       Date:  2021-09-22       Impact factor: 1.424

4.  Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis.

Authors:  Runze Wang; Cuixiu Peng; Junying Song; Yanan Hua; Qinglan Wu; Lin Deng; Yi Cao; Jinyu Zhang; Li Zhang; Li Wu; Lin Hou
Journal:  Int J Oncol       Date:  2022-02-18       Impact factor: 5.650

5.  Endocrine resistant breast cancer: brain metastasis.

Authors:  Matthew Willman; Jonathan Willman; Brandon Lucke-Wold
Journal:  Explor Target Antitumor Ther       Date:  2022-04-26

Review 6.  Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis.

Authors:  Yan Wang; Hangcheng Xu; Yiqun Han; Yun Wu; Jiayu Wang
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

Review 7.  An Insight into Molecular Targets of Breast Cancer Brain Metastasis.

Authors:  Mohammed Kaleem; Mahmood Hassan Dalhat; Lubna Azmi; Turky Omar Asar; Wasim Ahmad; Maimonah Alghanmi; Amal Almostadi; Torki A Zughaibi; Shams Tabrez
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

Review 8.  Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective.

Authors:  Arun Kadamkulam Syriac; Nitish Singh Nandu; Jose Pablo Leone
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-01-10

9.  Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series.

Authors:  Edy Ippolito; Sonia Silipigni; Paolo Matteucci; Carlo Greco; Francesco Pantano; Giuliana D'Auria; Carlo Cosimo Quattrocchi; Barnaba Floreno; Michele Fiore; Teresa Gamucci; Giuseppe Tonini; Sara Ramella
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.